학술논문

75MO Phase I trial of the DLL3/CD3 IgG-like T cell engager BI 764532 in patients (pts) with DLL3+ tumors: Focus on Asian pts.
Document Type
Article
Source
Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1495-S1495. 1p.
Subject
*T cells
*Q fever
*TUMORS
Language
ISSN
0923-7534